Dr. Kim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8081 Innovation Park Dr
Bldg B
Fairfax, VA 22031Phone+1 571-472-0606Fax+1 571-472-0540
Summary
- Dr. Daniel Kim is a radiation oncologist in Fairfax, VA and is affiliated with Inova Fairfax Medical Campus. He received his medical degree from Harvard Medical School and has been in practice 2 years. He specializes in central nervous system cancer, gastrointestinal cancer, and urologic cancer and is experienced in brachytherapy, stereotactic radiosurgery, proton beam therapy, intensity-modulated radiation therapy, and cyberknife radiosurgery. He has more than 40 peer reviewed publications and editor of the best-selling 1st edition textbook Translational Radiation Oncology.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2017 - 2021
- Brigham and Womens HospitalInternship, Preliminary Year, 2016 - 2017
- Harvard Medical SchoolClass of 2015
Certifications & Licensure
- VA State Medical License 2021 - 2026
- MA State Medical License 2016 - 2023
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- The impact of the titanium cranial hardware in proton single-field uniform dose plans.Peng Wang, Fionnbarr Timothy O'Grady, Martin Janson, Daniel Kim, Kevin S Choe
Journal of Applied Clinical Medical Physics. 2024-09-01 - 1 citationsFetal dose assessment in a pregnant patient with brain tumor: A comparative study of proton PBS and 3DCRT/VMAT radiation therapy techniques.Robabeh Rahimi, Michael Taylor, Xing Li, Kuan Ling Chen, Grayden MacLennan
Journal of Applied Clinical Medical Physics. 2024-08-01 - Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma.Grace Lee, Daniel W Kim, Alicia C Smart, Nora K Horick, Christine E Eyler
American Journal of Clinical Oncology. 2024-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: